Read the Conversation
Conversation highlights:
- Siemens Healthineers frames Argentina’s healthcare transformation around technology integration, with a strong focus on digitalization, interoperability, and AI-enabled diagnostics to improve system efficiency and clinical decision-making.
- Long-term public-private collaboration emerges as a central pillar, with sustainable healthcare models requiring a balance between competition and partnership across an increasingly complex ecosystem.
- Argentina stands out for its strong talent base and growing regional potential, particularly beyond Buenos Aires, positioning the country as a relevant hub for deploying and adapting global healthcare capabilities.
- Despite healthcare spending exceeding 9% of GDP, system fragmentation and financial pressures continue to limit efficiency, highlighting a critical gap between investment levels and real outcomes.
- The competitive landscape is becoming more collaborative, with multinational players across diagnostics, medtech, and data increasingly shaping an interconnected ecosystem that supports innovation and system modernization.
EF: What is your mission as Director General of Siemens Healthineers in Argentina, and how are you positioning the company as a strategic partner to the healthcare ecosystem?
MA: At Siemens Healthineers, we see ourselves as agents of change in the healthcare sector, bringing more than 125 years of global experience and decades of local presence in Argentina. Argentina has one of the most developed healthcare systems in the region, but it also faces important structural challenges: fragmentation, financial pressure, and the need for technology modernization. The country spends more than 9% of GDP on healthcare — one of the highest rates in Latin America — yet the core challenge is not how much is invested but how those resources are used to ensure access to quality care.
From our position as a strategic partner, I see transformation depending on five interconnected areas: technology integration, centralization of clinical processes, systems interoperability, access to long-term financing, and collaboration between public and private sectors. At Siemens Healthineers, we work alongside the local industry to deliver imaging, laboratory diagnostics, and digital solutions that improve clinical precision and operational efficiency. We also integrate therapy technology, which expands cancer treatment capabilities and supports a more comprehensive approach to patient care. Artificial intelligence connects these dimensions, linking imaging and diagnostics with therapy, to scale precision and personalized medicine. Our commitment in Argentina is to collaborate, innovate, and execute with a long-term vision.
EF: How is Siemens bringing digitalization and AI to Argentina, and how would you rate the level of adoption in the country?
MA: Our overarching framework is ‘Elevating Health Globally,’ a five-year strategy built around improving healthcare for patients, customers, and society. The key test of any global strategy is how it lands locally or how well it translates into solutions for specific national needs. In Argentina, that means paying close attention to non-communicable diseases, which account for more than 75% of deaths globally and follow a similar pattern here.
Artificial intelligence sits at the center of how we create impact. Picture a triangle: one vertex holds the best imaging and laboratory diagnostics; another holds therapy; the third holds healthcare AI, which connects and amplifies both, turning large-scale clinical data into precision and personalized medicine. At Siemens Healthineers, we develop enterprise-level AI solutions that streamline clinical routines across diagnosis and complex therapy. We call this our AI factory: an integrated infrastructure of hardware, software, and expert knowledge that produces three core outputs — enhanced imaging and advanced diagnostics, improved data integration, and greater clinical efficiency and productivity.
On adoption, Argentina is at an early but accelerating stage. The appetite among both public and private providers is real, and we are seeing growing demand for AI-assisted diagnostics, particularly in radiology and pathology. The constraint is less about willingness and more about infrastructure readiness and financing, both of which are improving as macroeconomic conditions stabilize.
EF: What initiatives does your company have in Argentina to ensure technology is used properly in hospitals, and how are you building training programs with hospital technicians?
MA: Across our diagnostics, imaging, laboratory, and therapy divisions, we follow a consistent methodology: first, understand the customer’s actual needs; second, provide the most appropriate solution; third, and very critically, ensure the technology is used to its full potential through structured training.
Training is not a one-time event for us. We begin with foundational and advanced training at the point of installation, then maintain ongoing support and refresher programs throughout the equipment’s operational life. In Argentina specifically, we are working with universities and clinical networks to develop virtual training environments that allow technicians to build proficiency with complex equipment without requiring physical access to the machines. This is particularly valuable in reaching institutions outside Buenos Aires, where specialist support has historically been harder to access. The broader shift toward digital and virtual learning tools is allowing us to reach more users, more efficiently, and with more consistent quality than traditional on-site training alone.
EF: How are you collaborating on the public-private side to show that these solutions are necessary for Argentina and build the ground for value-based healthcare solutions?
MA: The foundation of value-based healthcare is demonstrating that better technology produces better patient outcomes at a manageable cost , and that requires public and private actors working from the same evidence base. At Siemens Healthineers, we bring global case studies and outcome data to those conversations, helping policymakers and health system administrators understand what is possible and what it takes to get there.
Strong public-private partnerships are essential for modernizing Argentina’s healthcare infrastructure, and they need to be long-term and strategic rather than transactional. Our role is to support those partnerships with expanded diagnostic and treatment capabilities, digital infrastructure, and telemedicine solutions that help manage population health more efficiently, particularly in underserved regions where gaps in access are most acute.
Two enabling conditions matter enormously here. The first is long-term financing: both local and international funding mechanisms are needed to support large-scale infrastructure projects, and economic stabilization is making those conditions more achievable. The second is operational efficiency, because the supply of qualified healthcare professionals is not growing at the pace of demand, technology must extend the capacity of existing staff and improve return on investment for institutions in both sectors. Sustainability is also a commitment we take seriously: we are working toward carbon-neutral operations by 2030, and we integrate environmental considerations into how we design and deliver our solutions in Argentina.
EF: Why is a dollar invested in Argentina today invested better than anywhere else?
MA: Latin America is home to more than 600 million people, and Argentina ranks among the three most significant markets in the region alongside Brazil and Mexico. The case for investing here now rests on a convergence of factors that has not been available in recent years.
Macroeconomic conditions are improving in a meaningful way. Investor confidence, which was severely constrained for much of the past decade, is returning. At the German Chamber, we had the opportunity to discuss the outlook with a group of international banks, and their view was clear: Argentina is a credible destination for long-term financing. That signal from major funders matters because it de-risks the entry decision for other investors who have been waiting for that kind of institutional validation.
For healthcare specifically, the opportunity is substantial. With more than 45 million people and a system where equipment obsolescence is widespread, the demand for modernization is real and urgent. I have seen the pattern in other Latin American markets — Mexico, Peru, Colombia, Chile, Brazil — where healthcare investment arrived, transformed the system, and generated strong returns. Argentina is at that inflection point now. The homework is being done. If confidence continues to build from an international perspective, Argentina can move in a fundamentally different direction than it has in the past. The moment to pay attention is now.
EF: What legacy would you like to build in this sector, and how would you like to be remembered as a leader?
MA: Legacy, for me, starts with patients. We work in an industry where the person in the imaging suite or the laboratory could be our own family member. That is not an abstraction; it shapes how seriously I take every decision about quality, access, and care. When patients receive the right diagnosis at the right time because a hospital has the right technology and well-trained staff, that is the outcome that everything else is in service of.
The second dimension is customers: when health institutions trust Siemens Healthineers not just as a supplier but as a long-term partner, and when they feel genuinely supported in getting the most from the technology we provide, that relationship is something I am proud to build.
The third is people. Building and developing a strong team by creating real opportunities for talented individuals to grow is something I care about deeply. The measure I value most is when someone I worked with years ago, a colleague or even a customer, reaches out because they want to keep growing together. That continuity means something.
I am fortunate to have worked across different parts of the world with organizations I admire. Being here in Argentina at this particular moment carries real responsibility. My commitment is to bring everything I have learned — the experience, the networks, the standards — and make it genuinely useful for this country and its people. If I can transmit that honestly and with energy, I think I can contribute something lasting to this system.
